MedPath

Electronic Hand Hygiene Monitoring and ICU Infection Rates

Completed
Conditions
Cross Infection
Interventions
Other: Weekly poster of unit performance
Other: Daily email of personal feedback
Other: Active reminder from badge
Registration Number
NCT02511925
Lead Sponsor
Royal Brompton & Harefield NHS Foundation Trust
Brief Summary

If patients acquire a new infection whilst in hospital this can cause significant morbidity, prolonged hospitalisation and even death. Indeed, there is much public concern about infections such as MRSA. Patients who require intensive care are probably at the greatest risk.

Appropriate hand hygiene by healthcare workers can reduce infection rates and is a key goal of many patient safety initiatives. Worldwide, hand hygiene compliance has been estimated at only 38.7% despite the intervention being simple and cheap. Reasons for poor compliance include lack of time, skin irritation, lack of facilities, intensity of workload and forgetfulness. Furthermore, since cross infection may not be apparent for some days, staff may not associate their (lack of) actions with having caused harm.

Measuring compliance levels enables staff to understand whether they could improve. Direct observation of staff is labour intensive and is not continuous or universal. We will monitor hand hygiene compliance with a newly developed electronic system (MedSense, General Sensing Inc.). We will use the data to provide feedback to the staff in several ways. We hypothesise that comprehensive personalised feedback will reduce healthcare associated infections. We will undertake the study in three intensive care units.

Detailed Description

All patients admitted to three intensive care units will be monitored for healthcare associated infections. In parallel the units will be cluster randomised to implement the electronic compliance monitoring in three different ways:

* Unit level feed back every week of current compliance for each of three staff groupings (doctors, nurses, allied health professionals)

* Personalised feedback in the form of an email at the end of a shift stating an individuals performance relative to the average for their professional grouping.

* Real time feedback in the form of a badge worn by the healthcare worker that vibrates when the system thinks they have missed or are about to miss an opportunity for hand hygiene.

All healthcare workers will receive the level of feedback defined in the randomisation for the duration of the three intervention periods. The units will cross-over with an interventing two week wash out period.

All personal feedback will be confidential and private to the individual.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1065
Inclusion Criteria
  • All patients admitted to the intensive care units
  • All healthcare workers caring for the patients on the intensive care units.
Exclusion Criteria
  • Healthcare workers with skin sensitivity to both alcohol hand rub and soap

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ICU Cluster 1Daily email of personal feedbackAdult Intensive Care Unit - Royal Brompton Hospital
ICU Cluster 2Weekly poster of unit performancePaediatric ICU - Royal Brompton Hospital
ICU Cluster 2Daily email of personal feedbackPaediatric ICU - Royal Brompton Hospital
ICU Cluster 3Daily email of personal feedbackAdult Intensive Care Unit - Harefield Hospital
ICU Cluster 1Weekly poster of unit performanceAdult Intensive Care Unit - Royal Brompton Hospital
ICU Cluster 2Active reminder from badgePaediatric ICU - Royal Brompton Hospital
ICU Cluster 3Weekly poster of unit performanceAdult Intensive Care Unit - Harefield Hospital
ICU Cluster 3Active reminder from badgeAdult Intensive Care Unit - Harefield Hospital
Primary Outcome Measures
NameTimeMethod
Composite health care infection rateUntil the end of the second calendar day following ICU discharge

One of the following three:

Bacteriological proven infection at a normally sterile site. The sterile sites vein considered are a prior defined as blood, broncho-alveolar lavage, urine sampled from a catheter, chest drain fluid, and surgical wounds. Blood cultures that grow normal skin commensals will be included Endotracheal secretions that culture organisms other than normal upper respiratory tract flora Clostridium difficult related diarrhoea

Secondary Outcome Measures
NameTimeMethod
Adverse event rate24 weeks
Incidence of catheter associated urinary tract infectionsUntil the end of the second calendar day following ICU discharge

CDC definition

Incidence of ventilator associated pneumoniaUntil the end of the second calendar day following ICU discharge

CDC definition

Incidence of surgical site infectionUntil the end of the second calendar day following ICU discharge

Public Health England definition

Incidence of central line associated blood stream infectionsUntil the end of the second calendar day following ICU discharge

CDC definition

Incidence of clostridium difficult diarrhoeaUntil the end of the second calendar day following ICU discharge

Public Health England definition

Incidence of acquisition of new methicilllin resistant staphylococcus aureusUntil the end of the second calendar day following ICU discharge
Incidence of secondary blood stream infectionsUntil the end of the second calendar day following ICU discharge

CDC definition

Incidence of antibiotic resistance infectionsUntil the end of the second calendar day following ICU discharge

Pre-defined as Acinetobacter baumanii, Pseudomonas aeroginosa (Extended-Spectrum Beta Lacatamase \[ESBL\] producing), Klebsiella penumoniae (ESBL producing), Escherichia coli (ESBL producing), Stenotrophomonas maltophilia, Serratia marcescens, Clostridium difficile, or MRSA.

Trial Locations

Locations (1)

Royal Brompton and Harefield NHS Foundation Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath